• Skip to main content
  • Skip to primary sidebar

Arla Foods Ingredients targets medical nutrition with new MCI solutions

Asia Food Journal
  • Home
  • Latest News
  • Channels
    • Packaging
    • Processing
    • Ingredients
    • Industry
    • Automation
    • Guest Posts
    • Market Trends
  • Subscribe
  • Advertise
  • Event Calendar
  • Contact Us
    • Submit Guest Posts
Share
Leaderboard of Asia Food Journal




Arla Foods Ingredients targets medical nutrition with new MCI solutions

April 30, 2025 by Asia Food Journal

MCI solutions

Courtesy of Arla Foods Ingredients

Arla Foods Ingredients is highlighting the potential of micellar casein isolate (MCI) to address the growing demand for high-quality ingredients for medical nutrition.

Rich in native protein, MCI is extracted from milk using gentle processing. Arla Foods Ingredients’ Lacprodan MicelPure® portfolio already includes a range of MCI solutions that are relevant for medical nutrition. It is now being expanded with the launch of new Lacprodan MicelPure® Medical, which is designed to meet the specific requirements of the category.

Leaderboard of Asia Food Journal

Malnutrition is a key driver of innovation in the global medical nutrition market, which is forecast to grow by five percent year-on-year to 2027 (CAGR 2024-2027).1 Between 2019 and 2024, 30% of global oral nutrition supplements (ONS) and 52% of tube-feed product launches made a malnutrition claim.2

Worldwide, an estimated 20-70 percent of cancer patients3,4, and 30-70 percent of older patients5, are undernourished, with an associated decline in quality of life and increased rate of mortality.5 However, research has shown that half of the patients recommended a medical nutrition plan struggle to complete it, with key reasons including unpleasant texture and taste.6,7

Lacprodan MicelPure® ingredients offer outstanding functionality, a milky, neutral taste that enables easy pairing with a wide range of flavours, and the low viscosity that patients prefer – even at high protein concentrations. Other benefits include unrivalled heat stability and process flexibility. This allows manufacturers to create high-protein products using direct or indirect UHT treatment, enabling ambient formats and a wide range of packaging options.

The portfolio includes Lacprodan MicelPure®, a standard MCI, which is ideal for milky oral nutrition supplements, including tube feeds, and Lacprodan MicelPure® Ins, an instantised format designed for ready-to-mix products. Both are available in organic versions.

The latest addition to the range is Lacprodan MicelPure® Medical, which has an adjusted mineral profile to meet specific requirements and recommendations for medical nutrition. Thanks to an improved extraction process, it also offers a higher microbiological grade than the other MCI ingredients in the range. All the ingredients in the portfolio are low in lactose and fat.

Mads Dyrvig, Head of Sales Development, Specialised Nutrition at Arla Foods Ingredients, said: “Our Lacprodan MicelPure® solutions are a great match for medical nutrition products that target protein malnutrition. Meeting patient needs for high protein content and quality, great taste and texture, and a wider variety of formats can enhance compliance with medical nutrition, helping to improve recovery and quality of life. Lacprodan MicelPure® offers great functionality and processing versatility, opening up exciting opportunities for product innovation in a fast-growing market.”

Arla Foods Ingredients will showcase the Lacprodan MicelPure® portfolio at Vitafoods Europe 2025 (stand 4D17). It will highlight new high-protein prototypes specially formulated for the EU market – a milky oral nutrition supplement and a vanilla pudding, both offering 13g of protein per 100ml, excellent mouthfeel, and a mild, pleasant taste.

Find out more about the Lacprodan MicelPure® medical nutrition range at: www.arlafoodsingredients.com/medical-nutrition/our-ingredients/micellar-casein-isolate/

1 Innova Market Sizing & Insights

2 Global data: Oral vs tube feeding: selected health claims as a % share of total launches tracked (July 2019-June 2024)

3 Beirer, A. Malnutrition and cancer, diagnosis and treatment. memo 14, 168–173 (2021). doi.org/10.1007/s12254-020-00672-3

4 Arends J. Malnutrition in cancer patients: Causes, consequences and treatment options. Eur J Surg Oncol. 2024 May;50(5):107074, Epub 2023 Sep 14. doi: 10.1016/j.ejso.2023.107074

5 World Health Organization, Regional Office for Europe, 2023. Disease-related malnutrition: a time for action.

6 FMCG Gurus’ Medical Nutrition Insights database, N: 12,000 from Brazil, China, France, Germany, Indonesia, Italy, Japan, South Korea, Spain, UK, US, Vietnam, 2023

7 Lindberg International, Qualitative study on medical nutrition, 2024

About Arla Foods Ingredients

​Arla Foods Ingredients is a global leader in improving premium nutrition. Together with our customers, research partners, suppliers, NGOs, and others, we discover and deliver documented ingredients and products that can advance lifelong nutrition for the benefit of consumers around the world.

We serve leading global brands in early life nutrition, medical nutrition, sports nutrition, health foods, and other foods and beverages.

Five reasons to choose us:

  • We’re passionate about improving nutrition
  • We innovate by connecting the best
  • We master both discovery and delivery
  • We build strong, long-lasting partnerships
  • We are committed to sustainability

Headquartered in Denmark, Arla Foods Ingredients is a 100% owned subsidiary of Arla Foods.

https://www.arlafoodsingredients.com

Other Topics: Arla Foods Ingredients, Ingredients, MCI Solutions, Medical Nutrition

Related Articles

  • Vertis PB Pea

    Courtesy of DiTales Studio

    Meala partners with dsm-firmenich to commercialize texturizing protein for meat alternatives
  • GLP-1

    Courtesy of IFF

    IFF unveils game-changing outlook on GLP-1 consumers
  • Arla Foods Ingredients and MasterSense

    Courtesy of Arla Foods Ingredients

    Arla Foods Ingredients and MasterSense sign new distribution agreement for Chilean market
  • HMO Regulatory Approval

    Courtesy of dsm-firmenich

    Regulatory approval for dsm-firmenich’s 2’-FL HMO ingredient in Indonesia: Safety clearance allows new market access
  • Lee Kum Kee at THAIFEX 2025

    Courtesy of Lee Kum Kee

    Lee Kum Kee at THAIFEX 2025: Connecting the world through Asian culinary culture
  • Arla Foods Ingredients and Alchemy Agencies

    Courtesy of Arla Foods Ingredients

    Arla Foods Ingredients and Alchemy Agencies sign new distribution agreement
Leaderboard of Asia Food Journal

Primary Sidebar

Stay Connected

Your browser does not support the video tag. Learn More




🔥 Trending News

Blue Bottle Coffee announces opening of first Southeast Asian outlet in LUMINE
Farmlore in Bengaluru is unveiled as the winner of the American Express One to
Syensqo achieves breakthrough in mechanical recycling of PVDC multilayer
Blue Bottle Coffee announces opening of first Southeast Asian outlet in LUMINE

Trending News

Subsribe to Our News Letter

Subscribe To
Our Newsletter


By submitting this form, you consent to receive marketing emails from Asia Food Journal. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.

© 2025 Harvest Information. All rights reserved. Privacy Policy.

Become an F&B industry insider

Your go-to resource for all the latest trends, innovations, and news about the food and beverage industry!

 

By submitting this form, you consent to receive marketing emails from Asia Food Journal. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.

Disclaimer: Translations on this website are automated using Google Translate. While we strive for accuracy, please be cautious, as machine translations may contain errors. For critical or sensitive content, consider seeking professional human translation. We are not liable for any reliance on the translated content.